Non-viral targeted delivery system mediates transfection of thymidine kinase gene of herpes simplex virus into ovarian cancer cells:a comparison between one time and continuous mediation

被引:0
|
作者
Xiaojun Liu1
机构
关键词
ovarian cancer; gene therapy; targeted non-viral vector;
D O I
暂无
中图分类号
R737.31 [卵巢肿瘤];
学科分类号
100214 ;
摘要
Objective: To compare the transferring efficiency and killing effects of one time and continuous mediation with GE7,a non-viral targeted delivery system,in transfection of thymidine kinase gene of herpes simplex virus (HSV-tk) into ovarian cancer cells. Methods: GE7 was used to prepare recombinants with β-galactosidase (β-gal) and HSV1-tk; the re-combinants were then used to transfect human ovarian cancer line CaOV3 once and continuously. β-gal staining was used to compare the efficiencies of one time and continuous mediation with GE7 system. Ganciclovior (GCV) was introduced into HSV1-tk transfected ovarian cells. Through drawing the cell growth curve and flow cytometry,the killing effects of GCV on once and continuously GE7/HSV1-tk transfected cells were observed. Results: We found that the one time and continuous exogenous gene transfer efficiencies were about 80% and 85%,respectively. When 1μg/mL GCV was used to treat ovarian cell transfected with HSV1-tk gene,growth inhibiting rates of ovarian cells of one time and continuous transferring were 82% and 90%,respectively; their apoptosis indices were 15 and 30,respectively. Under same GCV concentration,continuous me-diation of GE7/pCMV-tk transfection into ovarian cancer cells had more significant inhibitory effect than one time mediation (P<0.05). Conclusion: Compared with one time mediation,continuous mediation of transfection with GE7 gene delivery system has higher efficiency. Continuous mediation of GE7/HSV1-tk/GCV therapeutic gene system has more powerful killing effect.
引用
收藏
页码:368 / 371
页数:4
相关论文
共 13 条
  • [1] Systemic Delivery of Modified mRNA Encoding Herpes Simplex Virus 1 Thymidine Kinase for Targeted Cancer Gene Therapy
    Wang, Yuhua
    Su, Hsing-hao
    Yang, Yang
    Hu, Yunxia
    Zhang, Lu
    Blancafort, Pilar
    Huang, Leaf
    MOLECULAR THERAPY, 2013, 21 (02) : 358 - 367
  • [2] Anti-tumor efficacy of the novel non-viral gene therapeutic system on the basis of herpes simplex virus thymidine kinase and GM-CSF
    Nemtsova, Elena
    Bezborodova, Olga
    Venediktova, Julia
    Alekseenko, Irina
    Monastyrskaya, Galina
    Rozencrants, Andrew
    Sobolev, Alexander
    Vinogradova, Tatyana
    Yakubovskaya, Raisa
    Sverdlov, Eugene
    Kaprin, Andrew
    HUMAN GENE THERAPY, 2014, 25 (11) : A56 - A57
  • [3] Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir
    Rosenfeld, ME
    Feng, MZ
    Michael, SI
    Siegal, GP
    Alvarez, RD
    Curiel, DT
    CLINICAL CANCER RESEARCH, 1995, 1 (12) : 1571 - 1580
  • [4] Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice
    Zhou, Xian-Long
    Shi, Yu-Lu
    Li, Xiong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (04) : 1159 - 1163
  • [5] Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer
    Kagaya, T
    Nakamoto, Y
    Sakai, Y
    Tsuchiyama, T
    Yagita, H
    Mukaida, N
    Kaneko, S
    CANCER GENE THERAPY, 2006, 13 (04) : 357 - 366
  • [6] Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer
    T Kagaya
    Y Nakamoto
    Y Sakai
    T Tsuchiyama
    H Yagita
    N Mukaida
    S Kaneko
    Cancer Gene Therapy, 2006, 13 : 357 - 366
  • [7] Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer
    Rancourt, C
    Rogers, BE
    Sosnowski, BA
    Wang, MH
    Piche, A
    Pierce, GF
    Alvarez, RD
    Siegal, GP
    Douglas, JT
    Curiel, DT
    CLINICAL CANCER RESEARCH, 1998, 4 (10) : 2455 - 2461
  • [8] Targeted gene therapy for cancer: Herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells
    Vile, RG
    Diaz, RM
    Castleden, S
    Chong, H
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 717 - 722
  • [9] Ectopic expression of herpes simplex virus-thymidine kinase gene in human non-small cell lung cancer cells conferred caspase-activated apoptosis sensitized by ganciclovir
    Chiu, CC
    Kang, YL
    Yang, TH
    Huang, CH
    Fang, K
    INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (04) : 328 - 333
  • [10] A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients
    Alvarez, RD
    Curiel, DT
    HUMAN GENE THERAPY, 1997, 8 (05) : 597 - 613